A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.

MLA

Eder, Ann-Christin, et al. “A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.” Pharmaceuticals (14248247), vol. 15, no. 3, Mar. 2022, p. 267. EBSCOhost, https://doi.org/10.3390/ph15030267.

APA

Eder, A.-C., Matthias, J., Schäfer, M., Schmidt, J., Steinacker, N., Bauder-Wüst, U., Domogalla, L.-C., Roscher, M., Haberkorn, U., Eder, M., & Kopka, K. (2022). A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer. Pharmaceuticals (14248247), 15(3), 267. https://doi.org/10.3390/ph15030267

Chicago

Eder, Ann-Christin, Jessica Matthias, Martin Schäfer, Jana Schmidt, Nils Steinacker, Ulrike Bauder-Wüst, Lisa-Charlotte Domogalla, et al. 2022. “A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.” Pharmaceuticals (14248247) 15 (3): 267. doi:10.3390/ph15030267.